Journal article · 2014
Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen
Forum, 29(6), 485–492 · Published 25 October 2014 · DOI 10.1007/s12312-014-1222-z
In brief
“Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen” is a 2014 journal article by Michael Hartmann, published in Forum. OpenAlex counts 1 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 1
- Most cited in
- 2015 (1)
- Field-weighted impact
- 0.55
- References
- 20
- Authors
- 1
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hartmann, M. (2014). Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen. Forum, 29(6), 485–492. https://doi.org/10.1007/s12312-014-1222-z
MLA 9
Hartmann, Michael. “Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen.” Forum, vol. 29, no. 6, 2014, pp. 485–492. https://doi.org/10.1007/s12312-014-1222-z.
Chicago
Hartmann, Michael. 2014. “Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen.” Forum 29 (6): 485–492. https://doi.org/10.1007/s12312-014-1222-z.
Harvard
Hartmann, M. (2014) ‘Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen’, Forum, 29(6), pp. 485–492. doi:10.1007/s12312-014-1222-z.
IEEE
M. Hartmann, “Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen,” Forum, vol. 29, no. 6, pp. 485–492, 2014, doi: 10.1007/s12312-014-1222-z.
BibTeX
@article{hartmann2014klinische,
title = {{Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen}},
author = {Hartmann, Michael},
journal = {Forum},
year = {2014},
volume = {29},
number = {6},
pages = {485--492},
doi = {10.1007/s12312-014-1222-z},
url = {https://doi.org/10.1007/s12312-014-1222-z}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- early benefit assessment
- added benefit
- risk-benefit assessment
- drug approval
- European Medicines Agency
- patient-relevant endpoints
- health technology assessment
- regulatory decision-making
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Hartmann, M. (2014). Klinische Krebsforschung im Wandel: Statistische Signifikanz, klinische Relevanz, Nutzenbewertung, Patientenpräferenzen. Forum, 29(6), 485–492. https://doi.org/10.1007/s12312-014-1222-z
How many times has this paper been cited?
1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Michael Hartmann.
What is the DOI of this paper?
10.1007/s12312-014-1222-z, permanently at https://doi.org/10.1007/s12312-014-1222-z. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.